Detalhe da pesquisa
1.
Cognitive and psychiatric adverse events during adjunctive cenobamate treatment in phase 2 and phase 3 clinical studies.
Epilepsy Behav
; 151: 109605, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184949
2.
Sudden unexpected death in epilepsy during cenobamate clinical development.
Epilepsia
; 64(8): 2108-2115, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37219391
3.
Sustainability of seizure reduction and seizure control with adjunctive cenobamate: Post hoc analysis of a phase 3, open-label study.
Epilepsia
; 64(10): 2644-2652, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37497579
4.
Incidence of mental health conditions by seizure control among adults with epilepsy in the United States.
Epilepsy Behav
; 134: 108865, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35952507
5.
Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open-label study.
Epilepsia
; 62(12): 3005-3015, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34633084
6.
Incremental burden of mental health conditions in adult patients with focal seizures.
Epilepsy Behav
; 112: 107426, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961390
7.
A global update on cenobamate based on real-world experience in over 100 000 patients.
Epilepsia
; 65(4): 1149-1150, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38446133
8.
Relative Bioavailability of Cenobamate Administered as a Crushed Tablet, Either Orally or via Nasogastric Tube, versus an Intact Whole Tablet.
J Clin Pharmacol
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683027
9.
Reductions in concomitant antiseizure medication drug load during adjunctive cenobamate therapy: Post-hoc analysis of a subset of patients from a phase 3, multicenter, open-label study.
Epilepsy Res
; 200: 107306, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340681
10.
Pharmacokinetics of cenobamate as monotherapy compared with adjunctive therapy.
Epilepsy Res
; 195: 107185, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37429218
11.
Real-world analysis of retention on cenobamate in patients with epilepsy in the United States.
Epilepsy Res
; 197: 107207, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37741165
12.
Efficacy of cenobamate by focal seizure subtypes: Post-hoc analysis of a phase 3, multicenter, open-label study.
Epilepsy Res
; 183: 106940, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35605481
13.
Post hoc analysis of a phase 3 study for treatment of uncontrolled focal seizures: Adjunctive cenobamate dose and seizure reduction by baseline seizure frequency.
Epilepsy Res
; 186: 107014, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36063589
14.
Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study.
Epilepsy Res
; 172: 106592, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33662894
15.
An Ex Vivo Evaluation of Cenobamate Administered via Enteral Tubes.
Drugs R D
; 20(2): 125-133, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32328931
16.
Reimplantation of an extruded osteoarticular segment of the distal tibia in a 14-year-old girl. Case report and review of the literature.
J Orthop Trauma
; 26(3): e24-8, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22048178
17.
Intramuscular lipoma of the supraspinatus causing impingement syndrome.
Orthopedics
; 32(8)2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19708627